DermTech, Inc. DMTK NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score

44/100

2/7 Pass

SharesGrow Intrinsic Value

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

DermTech, Inc. (DMTK) .

本页证实的标准:

VALUE (100/100, 通过) — 分析师目标价暗示上行空间 (+7878.7%).
分析师共识目标价 $7.50 (+7878.7% 上行空间) — 华尔街分析师认为存在显著上行潜力。

SharesGrow 综合评分： 44/100 其中 2/7 项标准通过。

SharesGrow 7-Criteria Score

44/100

SG Score

View full scorecard →

✓

价值

100/100

Price-to-Earnings & upside

Proven by this page

未來

52/100

Analyst consensus

→ Forecast

✗

过去

0/100

→ Income

✓

健康

75/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

15/100

→ Income

成长

58/100

→ Income

✗

收入

10/100

→ Income

估值概览 — DMTK

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.20

EV/EBITDA0.0

每股数据

EPS (TTM)$-3.09

每股账面价值$0.00

每股营收$0.47

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

分析师目标价$7.50 (+7878.7%)

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2012	$-0.65	$0.00	$-2.23M	-
2013	$-1.10	$0.00	$-5.18M	-
2017	$0.00	$0.00	$-60.00	-
2018	$0.36	$0.00	$856.41K	-
2019	$-3.13	$3.36M	$-21.9M	-651.1%
2020	$-2.05	$5.89M	$-36.48M	-619.8%
2021	$-2.71	$11.84M	$-78.34M	-661.7%
2022	$-3.88	$14.52M	$-116.68M	-803.7%
2023	$-3.09	$15.3M	$-100.89M	-659.6%